BPI-15086
BPI-15086 is an orally bioavailable, irreversible tyrosine kinase inhibitor selective for EGFR mutants, including the T790M resistance mutation. It is a research tool for studying non-small cell lung cancer (NSCLC) in both in vitro and in vivo experimental models.
Product Specifications
CAS Number
1644502-33-9
Field of Research
Cardiovascular Research, Immunology & Inflammation, Signal Transduction
Smiles
O=C (C=C) NC1=CC (NC2=NC=C (Cl) C (=N2) NC=3C=CC=CC3C (=O) C (=O) N (C) C) =C (OC) C=C1N4CCN (C) CC4
Molecular Formula
C29H33ClN8O4
Molecular Weight
593.08
Storage Conditions
-20°C
Notes
For research use only.
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
MBS2021030-01 24 Strip Well
Human Cholecystokinin A Receptor (CCKAR) ELISA Kit
Sign In for Pricing
View Details MBS2021030-02 48 Well
Human Cholecystokinin A Receptor (CCKAR) ELISA Kit
Sign In for Pricing
View Details MBS2021030-03 96 Well
Human Cholecystokinin A Receptor (CCKAR) ELISA Kit
Sign In for Pricing
View Details MBS2021030-04 5x 96 Well
Human Cholecystokinin A Receptor (CCKAR) ELISA Kit
Sign In for Pricing
View Details MBS2021030-05 10x 96 Well
Human Cholecystokinin A Receptor (CCKAR) ELISA Kit
Sign In for Pricing
View Details 